27 results
6-K
EX-99.1
BPTS
Biophytis
22 Feb 24
Publication of a book on the medicine and science of longevity
2:41pm
opportunity for the Company.
Far from the transhumanist myth of eliminating aging and death, the aim of this book is to mobilise society so that elderly
6-K
EX-99.1
BPTS
Biophytis
27 Sep 23
Half-year Financial Report
5:00pm
, adverse events (25% vs. 31%).Detailed results of the study were presented at the European Respiratory Society Lung Science Conference in March 2023 … in Estoril, Portugal and at the American Thoracic Society International Conference in Washington DC, United States in May 2023.
Based on the results
6-K
EX-99.1
BPTS
Biophytis
11 Sep 23
Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
9:52am
for effective therapeutics against a major disease in an aging society. We can count on the growing interest of the medical community in Europe and the United
6-K
EX-99.1
BPTS
Biophytis
20 Jun 23
Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
6:10am
in the 16th SCWD (Society on Sarcopenia, Cachexia & Wasting disorders) international congress, a flagship event bringing together experts from all over
6-K
EX-99.1
cgek41egn9nbik 1liw
25 May 23
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
11:00am
6-K
rbtp8lhbbh8
25 May 23
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
11:00am
6-K
EX-99.1
jkke1n6
28 Jun 22
Current report (foreign)
10:32am
20-F/A
8l2jtc0wgznr xs
28 Oct 21
Annual report (foreign) (amended)
5:16pm
20-F
sgitf86g k9utyh53wm
12 Mar 21
Annual report (foreign)
2:38pm
424B4
cmrt7zs0uq350
11 Feb 21
Prospectus supplement with pricing info
12:00am
FWP
b6n3l7b5kkddcy2b
8 Feb 21
Free writing prospectus
4:33pm
F-1/A
3hrv4xptivug2no
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
F-1/A
mp7ixltgq qj9ct
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1/A
EX-4.1
5k240cww q34
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
sk3hkcbz nmllkt
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
9r2v1ba7fr0j05v61wh4
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
sbcxy 0ah
20 Nov 20
Draft registration statement
12:00am